4 research outputs found
Latency-associated peptide (LAP) induces monocyte chemotaxis via a pathway distinct from TGF-Ī²1.
<p>C57BL/6 female mice were anesthetized and subcutaneously injected with Matrigelā¢ matrix supplemented with PBS, rhLAP or CCL2/MCP-1. After 10 days the mice were sacrificed, skinned, and the plugs were removed, fixed and embedded in paraffin then stained for CD68+ cells (mononuclear phagocytes). Matrigel matrix supplemented with (A) PBS, (B) 10 pg/ml rhLAP, or (C) 10 ng/ml CCL2 were assessed for CD68+ cell recruitment and then quantified by blinded counts (D). Arrow heads indicate CD68+ cells. (*p<0.05 for condition vs. PBS control plugs, nā=ā3 for CCL2 and nā=ā2 for LAP) Human monocytes (5Ć10<sup>4</sup>/condition) were suspended in Gey's balanced salt solution and assayed for their chemotactic response to rhLAP. Recruitment was assayed by incubating monocytes in modified Boyden chambers for 90 minutes at 37Ā°C and quantified by counting five high-powered fields of stained membranes in a blinded fashion. (E) Increasing doses of rhLAP (0-100 pg/ml) were used to stimulate monocyte recruitment (ā p<0.001 from the non-stimulated sample, nā=ā7). (F) Analysis for evidence of directed recruitment of monocytes by LAP was assessed by exposing monocytes to a ātrueā gradient of rhLAP (10 pg/ml) (rhLAP in the chamber opposite the monocytes <i>only</i>; dark barsāāMonocytesā) or no gradient (rhLAP on both sides of the chamber; lighter barsāāMonocytes+LAPā). These data represent two independent studies done in triplicate (*p<0.001 vs. mono + LAP condition). (G) Assessment of LAP-specific chemotaxis was performed by pre-incubating cell suspensions with the SB 431542 hydrate from Sigma (St.Louis, MO), a selective inhibitor of TGF-Ī² type 1 receptor kinases (Activin Receptor-Like Kinases, ALK-4,-5, and-7) 20 minutes prior to loading on chemotaxis chambers. Monocytes were then exposed to optimal chemotactic doses of LAP (10 pg/ml) and TGF-Ī²1 (100 pg/ml). All bars represent the meanĀ±SEM for nā=ā4 samples (* p<0.05 by ANOVA with post-hoc testing).</p
LAP-induced monocyte chemotaxis is blocked by specific inhibitors of LAP-TSP-1 interactions.
<p>Human monocytes (5Ć10<sup>4</sup>/condition) were suspended in Gey's balanced salt solution and assayed for their chemotactic response to rhLAP. Recruitment was assayed by incubating monocytes in modified Boyden chambers for 90 minutes at 37Ā°C and quantified by counting five high-powered fields of stained membranes in a blinded fashion and reported as fold-increase of LAP (10 pg/ml)-induced monocyte chemotaxis compared to monocyte chemotaxis induced by media alone. rhLAP at 10 pg/ml was chosen based on previous experiments that determined this dose induced maximal cellular recruitment. These data represent nā=ā3 (minimum) separate experiments expressed as the mean fold-changeĀ±SEM. Reported p values compare fold-change in monocyte chemotaxis induced by LAP without and with identified inhibitors.</p
LAP-induced inflammatory cell recruitment is altered in TSP-1 deficient (TSP-1 ā/ā) mice.
<p>(A) Bone marrow macrophages from wild type C57BL/6 or TSP-1ā/ā mice were isolated and assessed for chemotaxis activity using modified Boyden chambers. Macrophages (5Ć10<sup>4</sup>/condition) were suspended serum-free in Gey's balanced salt solution and chemotaxis was assayed by counting the mean of five blinded high-powered fields on the polycarbonate filter (ā p<0.001 for the chemotaxis of wild-type vs. TSP-1 ā/ā BMM). The data is expressed as fold-change in the mean compared to control (media alone)Ā±SEM for two independent studies done in triplicate. (B) LAP's ability to affect the direct DTHR was tested in TSP-1 ā/ā and wild-type mice. TSP-1 ā/ā and wild-type C57BL/6 mice were sensitized to tetanus toxin (TT) and then tested to confirm they had developed a TT-induced DTHR. This direct DTHR assay was performed in the pinnae of these mice with simultaneous injection (35 Āµl) of antigen (tetanus toxin) alone or with rhLAP (10 pg) (ā pā=ā0.004 for LAP-treated versus untreated WT mice, nā=ā3). All bars represent the meanĀ±SEM for two studies unless otherwise noted. DTHR, delayed-type hypersensitivity response; TT, tetanus toxin; WT, wild type, BKG, background ear girth.</p
LAP is able to suppress <i>in vivo</i> cellular inflammation similar to TGF-Ī²1 through interactions with thrombospondin-1.
<p>A transfer DTHR assay was performed with antigen (tetanus toxin) and tested agents (TGF-Ī²1, rhLAP and anti-TGF-Ī²1, LAP or TSP-1). C57BL/6 mice were sensitized to tetanus toxin (TT) and then tested to confirm they had developed a TT-induced DTHR. DTHR was induced in the pinnae of naĆÆve C57BL/6 mice with simultaneous injection (35 Āµl) of antigen and splenocytes (8Ć10<sup>6</sup> cells/condition) harvested from antigen-sensitized mice. DTHR was quantified by measurement of ear thickness 24 hours after injection. (A) LAP (10 pg) and TGF-Ī²1 (5 ng) were tested for the ability to reduce DTHR when used alone, with anti-TGF-Ī²1 antibodies (1 Āµg) or anti-LAP antibodies (1 Āµg) (*p<0.02 versus tetanus sensitized splenocytes + TT; ā p<0.01 versus tetanus sensitized splenocytes + TT, nā=ā5). Similar results were observed when this assay was repeated using C57BL/6 mice that had rejected a cardiac allograft (DBA/2->C57BL/6) as a model of transfer DTHR. (B) Anti-TSP-1 antibody or isogenic control IgG (all at 1 Āµg) were tested for their ability to interfere with rhLAP suppression of TT-induced DTHR (*p<0.02 versus tetanus sensitized splenocytes + TT; ā p<0.01 versus tetanus sensitized splenocytes + TT, nā=ā3). (C) Transfer DTHR assay was performed with antigen, rhLAP and the inhibitory peptide, LSKL or its scrambled control SLLK (20 ĀµM) (ā p<0.01 versus tetanus-sensitized splenocytes + TT, nā=ā2). (D) To determine if LAP used an IL-10 dependent pathway to inhibit the DTHR (as previously published) the DTHR transfer assay was repeated with anti-IL-10 antibodies and isotype control. (1 Āµg each) (*p<0.01 vs. tetanus-sensitized splenocytes + TT, nā=ā3) All bars represent the meanĀ±SEM. DTHR, delayed-type hypersensitivity response; Ag, Antigen; BKG, background ear girth.</p